NJIT
Synthesis and characterization of glycosaminoglycan mimetic variants for cartilage tissue engineering applications
Abstract
dc:description.abstract<p>Osteoarthritis is a degenerative joint disease where cartilage becomes damaged and can result in pain, loss of mobility, and decreased quality of life. Surgical and therapeutic strategies to treat cartilage damage remain inadequate. Sulfated glycosaminoglycans (GAGs), which are found in the native extracellular matrix, are known to interact with growth factors and thus, promote chondrocyte function. However, it is unclear what structural features in GAGs are critical for promoting chondrogenesis. Therefore, this study generated GAG mimetics that vary in glycosidic linkage geometry, degree of sulfation (DOS) and monomer ring substitution and evaluated their effect on mesenchymal stem cell (MSC) chondrogenesis. Optimal GAG mimetics were determined for their potential use in cartilage tissue engineering applications. GAG mimetics were synthesized from cellulose (pSC), starch (SS), and chitin (ChS) with two degrees of sulfation (DOS), 0.5 or 1 sulfate(s) per monomer. pSC has beta glycosidic linkage, SS has alpha glycosidic linkage and ChS is beta-linked but has N-acetyl substituted glucose monomers. When used in soluble form in MSC pellet cultures, pSC and SS enhanced MSC deposition of chondrogenic matrix components over other mimetics and control culture media (without GAG mimetics). GAG mimetics were incorporated into gelatin scaffolds via electrospinning. The fibrous scaffolds containing higher DOS of pSC and SS had a high affinity for transforming growth factor beta 3 (TGF-β3), and promoted MSC chondrogenesis as demonstrated by greater collagen type II (COL2) deposition, ratio of COL2 to collagen type I (COL1), and gene expression for COL2, aggrecan, and Sox9. However, cells on scaffolds containing pSC at 1.1 DOS had significantly higher gene expression for hypertrophic markers vascular endothelial growth factor (VEGF) and collagen type X (COLX) whereas, cells on scaffolds containing SS at 1.5 DOS had lower levels of VEGF and COLX of these markers at later timepoints. The scaffolds containing GAG mimetics also promoted greater chondrogenesis over scaffolds containing the native GAG heparin. When cultures were subjected to physiological loading using a dynamic compression bioreactor, MSC chondrogenic differentiation on SS 1.5 containing scaffolds was more favorable than gelatin controls as indicated by the production of a more homogeneous cartilage-like matrix. This study demonstrated that GAG mimetics with high DOS and the alpha glycosidic linkage, starch sulfate, promoted chondrogenic differentiation and is promising for cartilage regeneration applications.</p>
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy in Biomedical Engineering - (Ph.D.)
- Discipline thesis:degree_discipline
- Biomedical Engineering
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Vincent, Richard David, Jr.
- Contributors dc:contributor
-
- Treena Livingston Arinzeh
- George Collins
- James P. O’Connor
Subjects
dc:subject × 6Identifiers
dc:identifier.*- Repository record dc:identifier
- https://digitalcommons.njit.edu/dissertations/1815